Cardiac Amyloidosis

Cardiac Amyloidosis is an uncommon yet serious medical condition characterized by the infiltration of amyloid proteins into the heart tissue, disrupting its normal function. These proteins, typically derived from misfolded antibodies or other precursor proteins, aggregate into insoluble fibrils, creating deposits within the heart. This accumulation adversely impacts the heart's structural integrity, hindering its ability to pump blood efficiently. The manifestation of symptoms such as fatigue, shortness of breath, and leg swelling underscores the severity of the condition. Due to its varied clinical presentation, diagnosing Cardiac Amyloidosis poses a significant challenge, emphasizing the importance of early detection for effective management. Treatment strategies may involve addressing the root cause, symptom management, and, in certain cases, resorting to organ transplantation. Ongoing research and advancements in diagnostic methods signify a collective effort to enhance outcomes and quality of life for individuals grappling with Cardiac Amyloidosis.